Acute myeloid leukemia: 2016 Update on risk-stratification and management-Reference-Cited by-同舟云学术

Acute myeloid leukemia: 2016 Update on risk-stratification and management

Published:2016-07-15 Issue:8 Volume:91 Page:824-846
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Estey Elihu¹

Affiliation:

1. Division of Hematology, University of Washington School of Medicine, Seattle, WA, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

Publisher

Wiley

Subject

Hematology

Reference124 articles.

1. Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or AML on outcome of AML-type chemotherapy;Estey;Blood,1997

2. A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: Results from the UK NCRI AML 17 trial in 1206 patients;Burnett;Blood,2015

3. Assessment of differences in patient populations selected for excluded from participation in clinical phase III acute myelogenous leukemia trials;Mengis;J Clin Oncol,2003

4. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swed- ish Acute Leukemia Registry;Juliusson;Blood,2009

5. Intensive induction is effective in selected octo- genarian acute myeloid leukemia patients: Prog- nostic significance of karyotype and selected molecular markers used in the European Leuke- miaNet classification;Wetzler;Haematologica,2014

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Association of Vitamin B12 and Folic Acid Levels with the Effects of Induction Chemotherapy in Acute Leukemia Patients;Istanbul Medical Journal;2024-05-24

2. Tripartite prehabilitation of patients with acute myeloid leukaemia and high-risk myelodysplastic syndromes during intensive chemotherapy before allogeneic haematopoietic stem cell transplantation (COHABILIT): protocol for an innovating prospective multicentre study;BMJ Open;2024-03

3. Identification of prognostic and driver gene mutations in acute myeloid leukemia by a bioinformatics analysis;Translational Cancer Research;2023-06

4. Prognostic value of NOX2 as a potential biomarker for lung adenocarcinoma using TCGA and clinical validation;Molecular Medicine Reports;2023-01-09

5. A retrospective study on effectiveness of combined recombinant human interferon-α-1b, interleukin-2, and thalidomide for the treatment of acute myeloid leukemia in various disease states;Annals of Translational Medicine;2022-12